Galmed Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.

About GLMD

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. 

CEO
Allen Baharaff
CEOAllen Baharaff
Employees
24
Employees24
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2000
Founded2000
Employees
24
Employees24

GLMD Key Statistics

Market cap
8.39M
Market cap8.39M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
64.33K
Average volume64.33K
High today
$0.36
High today$0.36
Low today
$0.33
Low today$0.33
Open price
$0.36
Open price$0.36
Volume
56.36K
Volume56.36K
52 Week high
$3.13
52 Week high$3.13
52 Week low
$0.33
52 Week low$0.33

GLMD Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.